Chase Investment Counsel’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Chase Investment Counsel’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,663	Closed	-$441K	–	125
2023 Q1	$441K	Hold	3,663	–	–	0.24%	67
2022 Q4	$420K	Buy	3,663 +94	+3%	+$10.4K	0.26%	61
2022 Q3	$365K	Hold	3,569	–	–	0.23%	61
2022 Q2	$362K	Hold	3,569	–	–	0.2%	75
2022 Q1	$415K	Hold	3,569	–	–	0.18%	72
2021 Q4	$406K	Buy	+3,569	New	+$407K	0.16%	79
2020 Q3	–	Sell	-3,520	Closed	-$369K	–	111
2020 Q2	$369K	Buy	+3,520	New	+$377K	0.19%	74

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Chase Investment Counsel's BSX.PRA Position: Q2 2023 in Review

Chase Investment Counsel sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 3,663 shares — an estimated $441K sold.

Chase Investment Counsel first reported a position in BSX.PRA in Q2 2020 and held it in 7 quarters. The position peaked at $441K in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Chase Investment Counsel reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Chase Investment Counsel sold 3,663 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $441K.
Chase Investment Counsel first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 7 quarters.
Chase Investment Counsel's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $441K in Q1 2023.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Chase Investment Counsel's 13F filing for Q2 2023, filed 28 Jul 2023.